Navigation Links
Angiotech Pharmaceuticals, Inc. announces financial results for the fourth quarter ended December 31, 2008
Date:3/5/2009

341) 341 h - Investment and other income 10,393 (5,422) i 4,971 Interest expense on long-term debt (51,748) 2,242 j (49,506) Write-down and other deferred financing charges - - - Write-down / loss on redemption of investments (8,157) 8,157 m - Write-down of assets held for sale - - - Write-down of goodwill - - - ------------------------------------------------------------------------- ------------------------------------------------------------------------- (49,853) 5,318 (44,535) ------------------------------------------------------------------------- ------------------------------------------------------------------------- (Loss) income from continuing operations before income taxes (70,592) 68,268 (2,324) Income tax (recovery) expense (14,545) 18,066 p 3,521 ------------------------------------------------------------------------- ------------------------------------------------------------------------- (Loss) income from continuing operations (56,047) 50,202 (5,845) Net loss from discontinued operations, net of income taxes (9,893) 9,893 - ------------------------------------------------------------------------- Net (loss) income for the period $ (65,940) $ 60,095 $ (5,845) ------------------------------------------------------------------------- Basic and diluted net (loss) income per common share from continuing operations $ (0.66) $ (0.07) ----------------------------------------------------------
'/>"/>
SOURCE Angiotech Pharmaceuticals, Inc.
Copyright©2009 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20 21 22 23 24 25 26 27 28

Related biology technology :

1. Angiotech Pharmaceuticals, Inc. announces new Senior Secured Term Loan and Credit Facilities
2. Angiotech Pharmaceuticals announces time change of conference call and webcast
3. Angiotech announces termination of note purchase agreement with Ares Management and New Leaf Venture Partners
4. Angiotech Announces Webcast and Call-in Numbers for Annual and Special General Meeting of Shareholders
5. Angiotech Announces Extension of the Expiration Date of its Tender Offer for Senior Floating Rate Notes Due 2013 and 7.75% Senior Subordinated Notes Due 2014
6. Angiotech receives CE Mark approval of HemoStream(TM) Chronic Dialysis Catheter
7. Angiotech wins before the UK House of Lords
8. Angiotech to Establish Separate Operating and Royalty Businesses
9. Angiotech To Commence Cash Tender Offer for Senior Floating Rate Notes Due 2013 and 7.75% Senior Subordinated Notes Due 2014
10. Angiotech announces market launch of Quill(TM) SRS MONODERM(TM)
11. Angiotechs corporate partner, Cook Medical, announces positive interim results for its Zilver(R) PTX(TM) clinical study
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:1/14/2014)... , Jan. 14, 2014 As pet owners drew up ... many of them wrote: "Take better care of my furry companion." ... designer clothes and top-brand carrying cases to take the little canine ... might also feel compelled to buy some pricey toys at the ...
(Date:1/14/2014)... iLab Solutions, the leader in core facility management ... Product Strategy. In this role, Michelle will work with current ... in the development of iLab products. Her main goal will ... to the scientific community by offering the most advanced, user-friendly, ...
(Date:1/14/2014)... Kinaxis ®, provider of RapidResponse ®, a cloud-based supply ... ( S&OP ) service, is proud to be a gold ... held at the Hilton San Diego Bayfront, January 30 – ... Kaszas , Director of Supply Chain at Amgen, as she ...
(Date:1/14/2014)... 14, 2014 Independent publisher Bitingduck Press, ... Montreal, Canada, has big ideas for 2014 in production ... goals are to produce high-quality, low-cost, DRM-free ebooks and ... businesses. , The first major development will be ...
Breaking Biology Technology:New Year's Resolution: Give Pets the Gift of Top-Notch Health Care 2iLab Solutions Announces Michelle Detwiler as the New Director of Product Strategy 2Event Alert: Kinaxis Customer to Present at the Biomanufacturing Summit "Supply Chain: Improving Network Effectiveness" 2Bitingduck Press Looks Forward to 2014 With Multimedia E-books 2
... June 8 CSL Limited (ASX: CSL) and Talecris Biotherapeutics, ... their merger agreement, announced on August 12, 2008, under which ... , , Dr. Brian McNamee, CEO and Managing Director ... Federal Trade Commission (FTC) resolved to block the transaction. ...
... Calif., June 8 Proteolix, Inc. today announced data from ... for the treatment of multiple myeloma at the 14th Congress ... Carfilzomib is the first in a new class of selective, ... of hematologic malignancies and solid tumors. , ...
... 8 /PRNewswire/ -- Pasteuria Bioscience announced that ... Agency (EPA) for Pasteuria usgae . This is ... spp., a natural bacteria prevalent in soil that have ... nematodes. , , "We,re very pleased to ...
Cached Biology Technology:CSL Limited and Talecris Biotherapeutics Agree to Terminate Merger Agreement 2CSL Limited and Talecris Biotherapeutics Agree to Terminate Merger Agreement 3Proteolix Presents Clinical Data from Two Clinical Studies of Carfilzomib in Multiple Myeloma at the 14th Congress of the European Hematology Association 2Proteolix Presents Clinical Data from Two Clinical Studies of Carfilzomib in Multiple Myeloma at the 14th Congress of the European Hematology Association 3Proteolix Presents Clinical Data from Two Clinical Studies of Carfilzomib in Multiple Myeloma at the 14th Congress of the European Hematology Association 4Proteolix Presents Clinical Data from Two Clinical Studies of Carfilzomib in Multiple Myeloma at the 14th Congress of the European Hematology Association 5Pasteuria Bioscience Receives EPA Registration for Nematode Control 2
(Date:4/23/2014)... Like a hungry diner ripping open a dinner roll, ... must tear open a hydrogen molecule. Now researchers have ... the two halves of its hydrogen feast. The view ... make the catalyst work better for alternative energy uses. ... shown precisely where the hydrogen halves end up in ...
(Date:4/23/2014)... 23 2014) A team of researchers ... (hNSCs) into the brains of nonhuman primates and ... 24 months found that the hNSCs had differentiated ... cause tumors. , The study will be published ... but is currently freely available on-line as ...
(Date:4/23/2014)... have found evidence of an interaction between prenatal ... behavior in children, especially in girls. , "The ... to prenatal smoking will have behavioral problems. ... Boutwell, Assistant Professor at Sam Houston State University, ... the study. "One possible explanation for this ...
Breaking Biology News(10 mins):Halving hydrogen 2Halving hydrogen 3Halving hydrogen 4Study finds long-term survival of human neural stem cells transplanted into primate brain 2Genetics risk, prenatal smoking may predict behavioral problems 2
... head. What do you do? You probably first move out of ... object is. Your brain is able to quickly switch from detecting ... is through a phenomenon called adaptation. A new study in ... Neuroscience details the biological basis of this ability for rapid ...
... , WASHINGTON, D.C., November 21, 2010 -- Jump ropes are ... But what about the underlying physics? How do jump ropes ... Aristoff and Howard Stone of Princeton University have built themselves ... parameters -- rope rotation rate, rope density, diameter, length, and ...
... The Innovative Vector Control Consortium (IVCC) has received $50 ... continue its work to develop new insecticides for the ... malaria, dengue and other neglected tropical diseases. ... grant of $50.7 million over five years from the ...
Cached Biology News:Study reveals neural basis of rapid brain adaptation 2Study reveals neural basis of rapid brain adaptation 3
MOUSE ANTI GUINEA PIG T-CELLS (PAN):FITC Immunogen: Guinea pig peritoneal T-cells...
... Error-free cloning of BAC (100+kb), fosmid ... Greater insert stability than any othe BAC ... for high yields and easy recombinant DNA ... or transcription-free (pSMART VC) vectors for the ...
... Error-free cloning of BAC (100+kb), fosmid ... Greater insert stability than any othe BAC ... for high yields and easy recombinant DNA ... or transcription-free (pSMART VC) vectors for the ...
Anti-Goat HRP-AEC Cell & Tissue Staining Kit...
Biology Products: